Article Details
Retrieved on: 2022-12-31 08:26:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
It's the second foreign COVID-19 treatment cleared for use in China after authorities gave Pfizer's Paxlovid the go-ahead in early 2022.
Article found on: www.spokesman.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here